Industry Events

A hands-on workshop with localization experts from across the globe. Enjoy food and beverages on arrival.

Workshop Overview

Wire-free devices have fast established themselves as the future for tissue localization, but how can you truly unlock the full potential of a seed program? With Magtrace®, the world’s only paramagnetic lymphatic tracer.

Join a panel of experts from the US and Europe at the 2024 ASBrS Annual Meeting, as they share the extensive data proving the complete magnetic approach to increase efficiencies. Plus, take part in a hands-on demonstration of the latest techniques utilizing Sentimag® — the only platform capable of supporting accurate localization and staging.

Main Takeaways

• Find out how a complete magnetic approach to lesion localization and SLNB can eliminate your reliance on nuclear medicine and provide better economic efficiencies
• See why Magtrace® is ideal for all SLNB and how it outperforms all lymphatic tracers post-NAC
• Find out how adopting the full Sentimag® platform could SAVE your hospital money
• One year in... hear how the new Sentimag® has demonstrated greater accuracy and oncoplastic benefits
• Get hands-on by performing the techniques on our life-like breast surgery simulator models — with help and advice from our faculty

Faculty

Dr. Kristalyn Gallagher (Moderator) 🇺🇸 / Dr. Andreas Karakatsanis 🇸🇪 / Mr. Michael Boland 🇮🇪 / Dr. Patrick Borgen, MD 🇺🇸 / Dr. Michael Alvarado 🇺🇸 / Dr. Kandace McGuire 🇺🇸 / Dr. Eirini Pantiora 🇸🇪

Overview

Join speakers, Drs. Yao, Lipsyc-Sharf and Racz, as they review the expanded use of Oncotype DX Breast Recurrence Score test in early-stage breast cancer patients, as well as the use of germline testing and molecular residual disease (MRD) in breast cancer patients.

Faculty

• Katharine A. Yao, MS, MD
  Vice Chair of Research, department of Surgery
  Director, Breast Cancer Research Program
  Program Director, Surgical Outcomes Research, Outcomes Research Network
  NorthShore University Health System
• Marla Lipsyc-Sharf, MD
  Health Sciences Clinical Instructor of Medicine
  Translational Oncology Research Laboratory of the Jonsson Comprehensive Cancer Center
  University of California – Los Angeles
• Jennifer Racz, MD
  Director, Medical Affairs, Oncology
  Exact Sciences

Overview

Join us as we take a dive deep into how tumor-informed molecular residual disease (MRD) testing is being integrated into clinical practice today as a valuable tool to help guide treatment decisions for patients with breast cancer. Our expert panel will review the various applications of tumor-informed ctDNA assessment in the neoadjuvant, adjuvant and surveillance settings.

Presenters

• Angel Rodriguez, MD
  Medical Oncologist, Breast Medical Director
  Natera
• Erica Giblin, MD
  Surgeon, Breast Cancer Specialist
  Ascension St. Vincent

Overview

Join our expert faculty for an interactive symposium to explore the important role of surgeons in genetic testing for newly diagnosed breast cancer patients and to address your broader questions around breast cancer management. The session will kick off with some friendly competition between Attendings and Fellows to see who can score higher on a breast cancer quiz. With your participation, the panel will then navigate the complexities of and share best practices for seamlessly integrating guideline-based care, including informed consent and genetic counseling, into your surgical practice.

Expert Faculty

• Dr. Lucy De La Cruz
  Chief of Breast Surgery Program, MedStar Georgetown University Hospital, Washington DC
• Dr. Kelly Hunt
  Professor and Chair of the Department of Breast Surgical Oncology, MD Anderson Cancer Center, Texas
• Dr. Eric Manahan
  General Surgeon, Hamilton Medical Center, Georgia

Overview

Please plan on attending this breakfast symposium where esteemed faculty, Abhishek Chatterjee, MD, MBA (Chief of the Division of Plastic Surgery; Division of Surgical Oncology at Tufts Medical Center in Boston, MA) and Devinder Singh, MD (Chief of Plastic Surgery, University of Miami Health System and Professor of Surgery in the Division of Plastic Surgery at the University of Miami Miller School of Medicine) will present a comprehensive review of recently published, compelling clinical evidence findings regarding the innovative use of closed-incision negative pressure therapy (ciNPT) to help minimize surgical site complications and post-operative challenges of oncoplastic breast surgery patients. Recent case studies will further highlight innovative approaches which help optimize patient outcomes in high-risk surgery.

Speakers

• Abhishek Chatterjee, MD, MBA
  Chief of the Division of Plastic Surgery
  Division of Surgical Oncology
  Tufts Medical Center
  Boston, MA
• Devinder Singh, MD
  Chief of Plastic Surgery
  University of Miami Health System
  Professor of Surgery, Division of Plastic Surgery
  University of Miami Miller School of Medicine
  Miami, FL

Speaker

• Jeff Gadsden, MD, FRCPC, FANZCA
  Duke University Medical Center

Objectives

• Explain the rationale and principles behind regional nerve blocks and infiltration techniques in breast surgery, with a focus on enhancing recovery and minimizing opioid usage.
• Gain proficiency in identifying relevant anatomical landmarks and nerve pathways pertinent to regional anesthesia in breast surgery procedures.
• Develop practical skills in performing various regional nerve blocks tailored to breast surgery, including pectoral nerve blocks, intercostal nerve blocks, and serratus plane blocks, utilizing advanced ultrasound-guided techniques.
• Incorporate the principles of the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act into pain management strategies, with an emphasis on utilizing non-opioid alternatives effectively to mitigate the risk of opioid dependence and addiction.
• Utilize 3D cadaveric models to enhance anatomical understanding and refine procedural skills in a simulated environment, with a focus on accurate nerve localization, needle placement, and administration of local anesthetics.
• Implement multimodal analgesia protocols that integrate regional blocks into a comprehensive pain management approach, incorporating non-opioid medications, adjuvant therapies, and patient-centered strategies to optimize pain control and enhance recovery outcomes.

Overview

During this symposium, Jaime Alberty MD, FACS (Breast Surgeon) and William Audeh MD, MS (Medical Oncologist & Chief Medical Officer at Agendia) will discuss the latest data and share case studies leveraging MammaPrint® + BluePrint® gene expression profiling to optimize treatment plans for patients with Early-Stage ER+ Breast Cancer.

Presenters

• Jaime Alberty, MD, FACS
  Director of Breast Surgery, Comprehensive Breast Center, Kings County Hospital
• William Audeh, MD, MS
  Medical Oncologist & Chief Medical Officer at Agendia

Overview

Join us for a special dinner program at ASBrS where our panel of experts discuss the latest technologies in localization and lymphatic mapping. Learn how the innovative design of the HydroMARK Plus tissue marker alleviates displacement during surgery. We’ll also hear from personal experience the impact magnetic lesion localization and lymphatic mapping had on cost and efficiency across the multidisciplinary breast care team.

Speakers

• Anjeanette Brown, MD, FACS
  AtlantiCare, New Jersey
• Kandace McGuire, MD, FACS
  Virginia Commonwealth University, Virginia
• Rhiana Menen, MD, FACS
  Mountain State Breast and General Surgery

For More Information

Please visit www.mammotome.com.

Overview

To celebrate ASBrS 2024 in Orlando and the spirit of the Magic Kingdom, MOLLI Surgical will host a “magic themed” dinner and panel of expert breast surgeons to discuss their best tips and tricks to improve the breast cancer patient experience. Get a first-hand glimpse of the latest innovations, programs and research in breast-conserving surgery and a special event at the end of the session.

Moderator

• Ananth Ravi
  CEO of MOLLI Surgical

Panel

• Andrea Abbott, MD
  Medical University of South Carolina
• Patrick Borgen, MD
  Maimonides Medical Center, New York
• Joshua Feinberg, MD
  Maimonides Medical Center, New York
• Nicole Look Hong, MD
  Sunnybrook Hospital, Toronto

Overview

This session will educate the audience on how to incorporate genetic and genomic testing insights into clinical practice in order to guide personalized and preventative care and optimize surgical decision making for patients.

Program Objective

Equip surgeons and APPs with the expertise and tools to seamlessly integrate genetic and genomic testing into clinical practice.

Hosted by

• Laura Brzeskiewicz, MS, CGC
  Manager, Oncology Medical Science Liaisons at Myriad Genetics

Guest Speaker

• David Weintritt, MD, FACS
  Breast Surgeon, Virginia Cancer Specialists Founder, National Breast Center and Foundation

For More Information

Contact Meagan Rumph, mrumph@myriad.com, 801-560-7410.

Overview

Legally Mine will show you how to stop the threat of lawsuits before they ever get started by protecting your assets in time tested and proven legal structures. These same structures allow us to help our tax attorneys save what you would normally pay in income taxes. These are little known tax helps that have significant case history and have stood the test of time.

About Us

Legally Mine is a legal services company designed to protect business and personal assets as well as finding legitimate means of lowering tax liabilities. The company has been in business in its current format since 2007 and currently has more than 12,000 clients primarily coming from the medical and dental communities. Our priorities are education of the medical and dental communities through our seminars and preparing our clients to defeat both trial attorneys and over burdensome taxes.

For more information, contact info@legallymine.com; 800-375-2453.

Overview

This lecture will focus on all types of breast localization, from wire to wire-free options and how each have the potential to increase patient comfort and surgery scheduling flexibility.

Speaker

• Steven Cai, MD, FACS

CME Information

World Class CME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians and designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. This activity is supported by an unrestricted educational grant from Hologic, Inc.